A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

NCT00399230 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: Optive

Sponsor

Innovative Medical